149 related articles for article (PubMed ID: 6722837)
1. Treatment of metastatic sarcomas with mitoxantrone.
Presant CA; Gams R; Bartolucci AA
Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
[No Abstract] [Full Text] [Related]
2. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
[No Abstract] [Full Text] [Related]
3. Phase II trial of mitoxantrone.
Anderson KC; Cohen GI; Garnick MB
Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Birch R
Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
[No Abstract] [Full Text] [Related]
5. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
Sordillo PP; Magill GB; Gralla RJ; Golbey RB
Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
[No Abstract] [Full Text] [Related]
6. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
[No Abstract] [Full Text] [Related]
7. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
Chan C; Bartolucci A; Brenner D; Presant C; Davila E; Carpenter J; Greco FA; Clamon G; Moore J
Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
[No Abstract] [Full Text] [Related]
8. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Bartolucci A
Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
[No Abstract] [Full Text] [Related]
9. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
[No Abstract] [Full Text] [Related]
10. Mitoxantrone in malignant melanoma.
Presant CA; Gams R; Bartolucci A
Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
[TBL] [Abstract][Full Text] [Related]
11. A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
Maki RG; Kraft AS; Scheu K; Yamada J; Wadler S; Antonescu CR; Wright JJ; Schwartz GK
Cancer; 2005 Apr; 103(7):1431-8. PubMed ID: 15739208
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
Thigpen JT; Samson MK
Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
[No Abstract] [Full Text] [Related]
13. Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
Saiki JH; Baker LH; Stephens RL; Fabian CJ; Kraut EH; Fletcher WS
Cancer Treat Rep; 1982 Aug; 66(8):1673-4. PubMed ID: 7105060
[No Abstract] [Full Text] [Related]
14. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
15. Phase II trial of mitoxantrone in patients with primary liver cancer.
Falkson G; Coetzer BJ; Terblanche AP
Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
[No Abstract] [Full Text] [Related]
16. Phase II trial of mitoxantrone in advanced colorectal cancer.
Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
[No Abstract] [Full Text] [Related]
17. [The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas].
Ishii T; Tatezaki S; Satoh T; Yonemoto T; Umeda T; Kitoh M
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2123-30. PubMed ID: 9388523
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
19. A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue sarcomas or bone sarcomas.
Gian VG; Johnson TJ; Marsh RW; Schuhmacher C; Lynch JW
J Exp Ther Oncol; 1996 May; 1(3):186-90. PubMed ID: 9414403
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
[No Abstract] [Full Text] [Related]
[Next] [New Search]